Reuters logo
BRIEF-Oncodesign Announces Positive Results For MNK1/2 Program
December 5, 2017 / 5:33 PM / 9 days ago

BRIEF-Oncodesign Announces Positive Results For MNK1/2 Program

Dec 5 (Reuters) - Oncodesign Sa:

* ANNOUNCES POSITIVE RESULTS FOR ITS MNK1/2 PROGRAM

* PROGRAM HAS IDENTIFIED INHIBITORY MOLECULES WITH HIGH SPECIFICITY

* PROMISING CELLULAR RESULTS ALLOWING A TRANSITION TO LEAD OPTIMIZATION PHASE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below